Loading...
XSHE
300049
Market cap2.63bUSD
Dec 05, Last price  
70.25CNY
1D
7.09%
1Q
9.17%
Jan 2017
235.32%
IPO
603.91%
Name

Inner Mongolia Furui Medical Science Co Ltd

Chart & Performance

D1W1MN
XSHE:300049 chart
P/E
164.32
P/S
13.80
EPS
0.43
Div Yield, %
Shrs. gr., 5y
0.52%
Rev. gr., 5y
10.16%
Revenues
1.35b
+16.93%
121,590,130126,413,281141,257,489179,975,339210,246,377301,658,211407,639,040523,483,188645,517,669604,191,265826,987,166849,675,042867,029,327831,739,342807,532,608898,483,2281,008,765,8621,153,733,8861,349,015,180
Net income
113m
+11.54%
22,608,68522,476,59925,816,98434,418,07446,853,13852,490,69641,137,5394,905,38587,235,29591,685,239121,047,92971,866,91035,416,10143,385,84961,905,64095,468,87897,889,810101,563,741113,285,447
CFO
221m
-27.38%
49,515,95717,846,52336,473,049049,198,38275,751,89285,883,73228,183,17150,875,669158,159,638148,843,876126,160,83478,347,686256,227,191200,151,631208,310,758189,461,778304,889,062221,408,410
Dividend
Jun 13, 20230.2 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Inner Mongolia Furui Medical Science Co., Ltd. operates as a professional medical service platform company. The company provides disease diagnosis, drug treatment, and chronic disease management products in the liver disease field. It also offers health management center and medical care services. The company was formerly known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company. Inner Mongolia Furui Medical Science Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.
IPO date
Jan 20, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT